Press Releases

PharmaForceIQ Launches Share of Answer Module to Evaluate and Act on AI Visibility

Share of Answer Connects AI visibility audits with prioritized actions to help biopharma teams improve how brands and disease education content are represented in AI-generated answers

One Year After Launch, Plasmidsaurus RNA-Seq Challenges RT-qPCR as the Standard for Routine Gene Expression Analysis

One year after launching its ultrafast RNA-Seq service, Plasmidsaurus has reached more than 9,000 researchers across 1,000+ institutions, processing hundreds of thousands of samples to date.

Yourgene Health Insight DPYD Assay Secures TGA Regulatory Approval in Australia

• Assay enables comprehensive pharmacogenetic testing to support safer, personalised chemotherapy treatment for cancer patients • Southern Cross Diagnostics to supply IVD assay to clinical diagnostics laboratories in Australia

START Expands its Global Early Phase Cancer Site Network into Italy Through Strategic Partnership with Istituti Fisioterapici Ospitalieri

The new START site at the IRCCS Istituto Nazionale Tumori Regina Elena will expand access to cancer clinical trials for patients in a major European oncology market.

Biognosys Launches Industrialized Discovery to Deliver Scalable, AI-ready Proteomics with Exceptional Cost Efficiency

Biognosys Group, a fully owned affiliate of Bruker Corporation, today announced the launch of Industrialized Discovery.

Lilly Brings FDA-Approved GLP-1 Treatments to Hims & Hers Digital Platform

Lilly and Hims & Hers have partnered to expand access to FDA-approved Zepbound and Foundayo through telehealth. Monthly self-pay prices start at $299 for Zepbound and $149 for Foundayo.

CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist

CluePoints, a leading provider of Risk-Based Quality Management (RBQM) and clinical data quality oversight software, has been named a finalist in the Data Analytics/Business Intelligence category at the 2026 Fierce Life Sciences Innovation Awards.

Takara Bio Europe Introduces GMP-Grade Cellartis® MSC EV Wonder™ to Support Clinical-Scale Extracellular Vesicle Production

Takara Bio Europe announces the introduction of a GMP-grade version of Cellartis® MSC EV Wonder™ for the efficient and scalable production of extracellular vesicles from human mesenchymal stem cells.

DCN Dx Acquires Human Biospecimen Provider BioSouthTech to Broaden Access to Diverse Patient Populations

DCN Dx has acquired BioSouthTech, expanding access to diverse patient populations and biospecimens across Latin America. The acquisition strengthens support for diagnostic and drug development in oncology, neurology, autoimmune disease, and infectious disease. Learn more: dcndx.com/services/biospecimen

Genefluence’s rapid, near-patient PCR test for urinary tract infections in first use at the Royal Hospital Chelse

Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen for urinary tract infections (UTIs), at the Royal Hospital Chelsea. The lab-free test is being used to identify, confirm and guide the treatment of UTIs on the spot, helping clinicians choose the most effective medication immediately rather than relying on trial-and-error broad-spectrum antibiotics – and helping to reduce the risk of antimicrobial resistance (AMR).

Samplix Secures Backing to Accelerate Xdrop’s Commercial Expansion in Antibody Discovery

Samplix today announced financing led by WLanholding GmbH to expand commercial adoption of Xdrop, its single-cell screening platform that helps researchers identify and recover cells producing antibodies with the desired biological function.

Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI facility

Ceryx Medical and King’s College London today announced that the first implantable device has been manufactured at MAISI, the national facility for the Manufacture of Active Implants and Surgical Instruments.

Baylor Genetics to Highlight Clinical and Diagnostic Utility of Genome Sequencing at the 2026 American Society of Human Genetics Annual Meeting

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced it will share new genome sequencing data in two platform presentations and a poster presentation at the 2026 American Society of Human Genetics (ASHG) Annual Meeting in Montréal, Québec, Canada from Oct. 20-24, 2026.

eClinical Solutions Expands Executive Leadership with Three Strategic C-Suite Appointments

eClinical Solutions announced three new leadership appointments, including Chief Product Officer (Nathan Johnson), Chief People Officer (Brian Testa), and Chief Financial Officer (Jessica Allen).

NeoGenomics Expands Indica Labs Partnership to Scale AI-Powered Digital Pathology

Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay

Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive genetic tests and diagnostic services, today announced the publication of its study "Diagnostic Yield of Genome Sequencing for Children with Intellectual Disability and Developmental Delay (ID/DD)” in Frontiers in Neurology.

CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins

The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category.

Clinion’s Agentic AI Assistant Named Finalist for Technology Innovation of the Year at the Citeline Biotech Awards 2026

The recognition highlights Clinion’s work applying governed, multi-agent AI to clinical data management and study intelligence.

New Clearwater Report Finds 91% of Healthcare Organizations Cannot Verify AI Governance For Their Organization Our mission is to help organizations across the healthcare ecosystem move to a more secure, compliant, and resilient state so they can achieve t

CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development

CellCarta today announced a strategic partnership with Waters Corporation creating a framework to jointly pursue companion diagnostic and next-generation flow cytometry opportunities with pharmaceutical and biotechnology companies.